Resistance to β-lactams in Streptococcus pneumoniae

Area of Science:

• Microbiology
• Infectious Diseases
• Antimicrobial Resistance

Background:

• Streptococcus pneumoniae causes pneumonia, meningitis, sepsis, bacteremia, and otitis media.
• Penicillin resistance in S. pneumoniae has shown stable rates in Argentina recently.
• High-level penicillin resistance (MIC ≥2μg/ml) peaked in the late '90s but has since declined.

Purpose of the Study:

• To analyze trends in penicillin resistance of Streptococcus pneumoniae in Argentina.
• To understand the mechanisms and factors influencing the spread of resistant strains.
• To provide guidance on effective antibiotic treatments for S. pneumoniae infections.

Main Methods:

• Monitoring of penicillin resistance rates in S. pneumoniae isolates.
• Analysis of phenotypic resistance mechanisms involving penicillin-binding proteins and gene structures.
• Evaluation of factors such as antibiotic usage, vaccination, and population density.

Main Results:

• Penicillin resistance rates in S. pneumoniae have remained stable in Argentina.
• A decrease in the frequency of high-level penicillin resistance (MIC ≥2μg/ml) has been observed.
• Mechanisms of resistance involve modified penicillin-binding proteins and mosaic gene structures.

Conclusions:

• Parenteral penicillin G is effective for pneumonia and bacteremia.
• Oral aminopenicillins are suitable for otitis media and sinusitis.
• Third-generation cephalosporins remain a treatment option for meningitis.